BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 19450267)

  • 1. Administration of follitropin alfa and lutropin alfa combined in a single injection: a feasibility assessment.
    Agostinetto R
    Reprod Biol Endocrinol; 2009 May; 7():48. PubMed ID: 19450267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the biopotency of follitropin alfa and lutropin alfa combined in one injection: a comparative trial in Sprague-Dawley rats.
    Alper M; Meyer R; Dekkers C; Ezcurra D; Schertz J; Kelly E
    Reprod Biol Endocrinol; 2008 Jul; 6():31. PubMed ID: 18647398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioequivalence of recombinant human FSH and recombinant human LH in a fixed 2:1 combination: two phase I, randomised, crossover studies.
    Picard M; Rossier C; Papasouliotis O; Lugan I
    Curr Med Res Opin; 2008 Apr; 24(4):1199-208. PubMed ID: 18348746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of follitropin alfa/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders.
    Humaidan P; Chin W; Rogoff D; D'Hooghe T; Longobardi S; Hubbard J; Schertz J;
    Hum Reprod; 2017 Mar; 32(3):544-555. PubMed ID: 28137754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized trial to compare the effect of recombinant human FSH (follitropin alfa) with or without recombinant human LH in women undergoing assisted reproduction treatment.
    Marrs R; Meldrum D; Muasher S; Schoolcraft W; Werlin L; Kelly E
    Reprod Biomed Online; 2004 Feb; 8(2):175-82. PubMed ID: 14989794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corifollitropin alfa compared with follitropin beta in poor responders undergoing ICSI: a randomized controlled trial.
    Kolibianakis EM; Venetis CA; Bosdou JK; Zepiridis L; Chatzimeletiou K; Makedos A; Masouridou S; Triantafillidis S; Mitsoli A; Tarlatzis BC
    Hum Reprod; 2015 Feb; 30(2):432-40. PubMed ID: 25492411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient evaluation of the use of follitropin alfa in a prefilled ready-to-use injection pen in assisted reproductive technology: an observational study.
    Welcker JT; Nawroth F; Bilger W
    Reprod Biol Endocrinol; 2010 Sep; 8():111. PubMed ID: 20843323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose accuracy of the follitropin alfa pen injector 2.0, the follitropin alfa:lutropin alfa 2:1 combination pen injector 2.0 and the choriogonadotropin alfa pen injector 1.0 used for fertility treatment.
    Cottell E; Michalet D; Lispi M; Araujo TD; Gleixner R; Longobardi S; D'Hooghe T
    Expert Opin Drug Deliv; 2024 Feb; 21(2):337-346. PubMed ID: 38299472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of Follitropin Alfa/Lutropin Alfa for Stimulation of Follicular Development.
    Abramova N; Hubbard J; Schertz J; Richter E
    Drug Saf; 2019 Mar; 42(3):453-461. PubMed ID: 30341677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Routine use of r-hFSH follitropin alfa filled-by-mass for follicular development for IVF: a large multicentre observational study in the UK.
    Lass A; McVeigh E;
    Reprod Biomed Online; 2004 Dec; 9(6):604-10. PubMed ID: 15670403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of new quality standards of follitropin alfa on ovarian stimulation: meta-analysis of previous studies.
    Saz-Parkinson Z; López-Cuadrado T; Bouza C; Amate JM
    BioDrugs; 2009; 23(1):37-42. PubMed ID: 19344190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lutropin alfa.
    Dhillon S; Keating GM
    Drugs; 2008; 68(11):1529-40. PubMed ID: 18627209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A large, multicentre, observational, post-marketing surveillance study of the 2:1 formulation of follitropin alfa and lutropin alfa in routine clinical practice for assisted reproductive technology.
    Bühler K; Naether OG; Bilger W
    Reprod Biol Endocrinol; 2014 Jan; 12():6. PubMed ID: 24423045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effectiveness of recombinant human follicle-stimulating hormone alfa (r-hFSH-alfa) versus highly purified urinary human menopausal gonadotropin (hMG HP) in assisted reproductive technology (ART) treatments: a non-interventional study in Germany.
    Bühler KF; Fischer R; Verpillat P; Allignol A; Guedes S; Boutmy E; Bilger W; Richter E; D'Hooghe T
    Reprod Biol Endocrinol; 2021 Jun; 19(1):90. PubMed ID: 34134695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A questionnaire-based survey to assess patient satisfaction, ease-of-learning, ease-of-use, injection site pain and overall patient satisfaction of the follitropin-alpha (Gonal-f) filled-by-mass (FbM) prefilled pen compared with other systems of gonadotrophin administration.
    Utsunomiya T; Tanaka A; Tatsumi K; Ezcurra D
    Reprod Biol Endocrinol; 2012 Nov; 10():93. PubMed ID: 23167906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human follicle-stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted reproductive technology: systematic review and meta-analysis.
    Lehert P; Kolibianakis EM; Venetis CA; Schertz J; Saunders H; Arriagada P; Copt S; Tarlatzis B
    Reprod Biol Endocrinol; 2014 Feb; 12():17. PubMed ID: 24555766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continued improvements in the quality and consistency of follitropin alfa, recombinant human FSH.
    Bassett RM; Driebergen R
    Reprod Biomed Online; 2005 Feb; 10(2):169-77. PubMed ID: 15823219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fine-tuning the dose of recombinant human follicle-stimulating hormone alfa to individualize treatment in ovulation induction and ovarian stimulation cycles: a real-world database analysis.
    Martini AE; Beall S; Ball GD; Hayward B; D'Hooghe T; Mahony MC; Collares F; Catherino AB
    Front Endocrinol (Lausanne); 2023; 14():1195632. PubMed ID: 37727455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lutropin alfa: new preparation. Combined with follitropin for follicular development: no better than menotropin.
    Prescrire Int; 2003 Jun; 12(65):91-2. PubMed ID: 12825571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor binding and functional properties of chimeric human follitropin prepared by an exchange between a small hydrophilic intercysteine loop of human follitropin and human lutropin.
    Dias JA; Zhang Y; Liu X
    J Biol Chem; 1994 Oct; 269(41):25289-94. PubMed ID: 7929221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.